- Exploring expansion of 무료 바카라 게임 services through synergy in 무료 바카라 게임 modality business via trilateral agreement
- Aims to enhance 무료 바카라 게임 capabilities through collaborative innovation with specialized partners
[by Sung, Jae Jun] LOTTE BIOLOGICS, Axcelead Drug Discovery Partners, Inc., and Kanaph Therapeutics Inc. announced on June 16 that they have signed a tripartite Memorandum of Understanding (MOU) to build an ADC Toolbox for the development of antibody-drug conjugates (ADCs).
Through this agreement, the three companies will collaborate on the joint research and development of linker and payload technologies, which are key components in the development of next-generation 무료 바카라 게임 cancer therapies.
Axcelead Drug Discovery Partners, Inc., a world-class drug discovery platform Contract Research Organization (CRO) by inheriting the drug discovery platform from Takeda Pharmaceutical Company in Japan, plans to leverage a compound library comprising more than 1.2 million compounds and more than 1,000 legacy projects to generate novel payload candidates not yet applied to 무료 바카라 게임s.
Kanaph Therapeutics Inc. will focus on developing an innovative platform that addresses the limitations of existing linker and payload technologies in 무료 바카라 게임 development.
The linker and payload technologies developed through this collaboration will be transferred to LOTTE BIOLOGICS, which will utilize them to further enhance the competitiveness of its 무료 바카라 게임 platform, including SoluFlex Link.
LOTTE BIOLOGICS plans to offer an 무료 바카라 게임 Toolbox service, enabling clients to select and apply a variety of technologies tailored to their needs. This service is expected to reinforce the company’s one-stop platform encompassing the entire 무료 바카라 게임 modality process—from research and development to GMP manufacturing.
A LOTTE BIOLOGICS representative said, “This agreement marks a step forward in building a differentiated 무료 바카라 게임 platform and toolbox. We will continue to strengthen our partnerships with both companies to enhance our competitiveness in the global market and deliver more innovative treatments to patients.”
Axcelead Drug Discovery Partners, Inc. representative said, “We are pleased to participate in this initiative to establish a strategic alliance dedicated to the development and further advancement of 무료 바카라 게임 platform technologies and services. Leveraging our proprietary drug discovery platform, we strive to contribute to the creation of innovative therapies.”
A representative from Kanaph Therapeutics Inc. added, “Through this collaboration, we are committed to establishing a versatile toolbox of linkers and payloads to overcome the limitations of existing 무료 바카라 게임s and accelerate the development of next-generation innovative therapeutics.”